Cite
HARVARD Citation
Dechow, T. et al. (2022). Pomalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of the non‐interventional study POSEIDON and comparison with the pivotal phase 3 clinical trials. European journal of haematology. pp. 133-144. [Online].